Sun Pharma shares fall to over 4-year low

Reuters | Updated on January 09, 2018 Published on August 09, 2017


Sun Pharmaceutical Industries' shares slumped as much as 5 per cent to their lowest since June 2013.

The company reported that Taro Pharmaceutical Industries Ltd's June-quarter profit halved to $54.5 million. Sun Pharma holds a majority stake in Taro.

Taro's Q1 net sales fell 31 per cent to $161.3 million, hurt by continuing increased competition and pricing environment

“We expect this product-specific pricing pressure to continue into the future,” Nirmal Bang Retail Research analysts wrote in a note, adding that this was a negative for Sun Pharma

Sun Pharma holds about 73 per cent stake in Taro as of March 2016, according to Thomson Reuters data

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on August 09, 2017
This article is closed for comments.
Please Email the Editor